Theriva Biologics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
Theriva Biologics, Inc. (TOVX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $41.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2023-03-30
- Theriva Biologics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $41.00K, a 28.13% increase from fiscal 2021.
- Theriva Biologics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2021 was $32.00K, a 0.00% change from fiscal 2020.
- Theriva Biologics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2020 was $32.00K, a 96.30% decline from fiscal 2019.
- Theriva Biologics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2019 was $864.00K, a 200.00% increase from fiscal 2018.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month as first filed |
|---|---|---|
| 2022-12-31 | $41.00K 10-K · filed 2023-03-30 | |
| 2021-12-31 | $32.00K 10-K · filed 2023-03-30 | |
| 2020-12-31 | $32.00K 10-K · filed 2022-03-16 | |
| 2019-12-31 | $864.00K 10-K · filed 2021-03-04 | |
| 2018-12-31 | $288.00K 10-K · filed 2020-02-20 | $266.00K 10-K · filed 2019-02-27 |
| 2017-12-31 | $502.00K 10-K · filed 2019-02-27 | |
| 2016-12-31 | $574.00K 10-K · filed 2018-02-22 | |
| 2015-12-31 | $877.00K 10-K · filed 2017-03-02 | |
| 2014-12-31 | $789.00K 10-K · filed 2016-03-10 | |
| 2013-12-31 | $511.00K 10-K · filed 2015-03-16 | |
| 2012-12-31 | $518.00K 10-K · filed 2015-03-16 | |
| 2011-12-31 | $366.00K 10-K · filed 2013-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |